These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10233942)

  • 1. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.
    Crawford SE; Estes MK; Ciarlet M; Barone C; O'Neal CM; Cohen J; Conner ME
    J Virol; 1999 Jun; 73(6):4813-22. PubMed ID: 10233942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.
    Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME
    Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.
    Ciarlet M; Crawford SE; Barone C; Bertolotti-Ciarlet A; Ramig RF; Estes MK; Conner ME
    J Virol; 1998 Nov; 72(11):9233-46. PubMed ID: 9765471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.
    Bertolotti-Ciarlet A; Ciarlet M; Crawford SE; Conner ME; Estes MK
    Vaccine; 2003 Sep; 21(25-26):3885-900. PubMed ID: 12922123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus subunit vaccines.
    Conner ME; Crawford SE; Barone C; O'Neal C; Zhou YJ; Fernandez F; Parwani A; Saif LJ; Cohen J; Estes MK
    Arch Virol Suppl; 1996; 12():199-206. PubMed ID: 9015116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particles as a rotavirus subunit vaccine.
    Conner ME; Zarley CD; Hu B; Parsons S; Drabinski D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Madore HP; Crawford S; Estes MK
    J Infect Dis; 1996 Sep; 174 Suppl 1():S88-92. PubMed ID: 8752296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.
    Madore HP; Estes MK; Zarley CD; Hu B; Parsons S; Digravio D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Crawford S; Conner ME
    Vaccine; 1999 May; 17(19):2461-71. PubMed ID: 10392629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homotypic and heterotypic immune responses to group A rotaviruses in parenterally immunized sheep.
    Beards GM; King JA; Mazhar S; Landon J; Desselberger U
    Vaccine; 1993; 11(2):262-6. PubMed ID: 8382420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.
    Brüssow H; Walther I; Fryder V; Sidoti J; Bruttin A
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1647-58. PubMed ID: 2839600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccine administered parenterally induces protective immunity.
    Conner ME; Crawford SE; Barone C; Estes MK
    J Virol; 1993 Nov; 67(11):6633-41. PubMed ID: 8411366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.
    Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB
    J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children.
    Gorrell RJ; Bishop RF
    J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic and mucosal immune response to rotavirus infection in the rabbit model.
    Conner ME; Gilger MA; Estes MK; Graham DY
    J Virol; 1991 May; 65(5):2562-71. PubMed ID: 1850029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
    Green KY; Taniguchi K; Mackow ER; Kapikian AZ
    J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype.
    Offit PA; Clark HF; Blavat G; Greenberg HB
    J Virol; 1986 Nov; 60(2):491-6. PubMed ID: 3021983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus virus-like particles administered mucosally induce protective immunity.
    O'Neal CM; Crawford SE; Estes MK; Conner ME
    J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.
    Ciarlet M; Estes MK; Barone C; Ramig RF; Conner ME
    J Virol; 1998 Mar; 72(3):2341-51. PubMed ID: 9499095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
    Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
    J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotaviruses: immunological determinants of protection against infection and disease.
    Offit PA
    Adv Virus Res; 1994; 44():161-202. PubMed ID: 7817873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.